IQVIA Standardizes on Four Veeva Clinical Apps Across Its Studies
Image
Research Triangle Park – October 13, 2026 -- IQVIA has selected four Veeva applications (CTMS, eTMF, Study Startup and Site Connect) as enterprise standards for its clinical development studies, extending a partnership that previously covered Veeva's EDC.
IQVIA and Veeva widen the clinical technology tie-up beyond EDC
IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) announced the expansion on Oct. 13, 2026. The companies say the combined offering is intended to raise trial speed and efficiency, strengthen site centricity and improve decision-making.
All Veeva clinical solutions are also available through IQVIA for sponsors that want a full Veeva technology stack.